Dentists in Blue Ridge, GA Accepting Medicare
7 Dentists found. Showing 1 - 7
 Dr. Ronnie L Hold, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 823 E Main St, Blue Ridge, GA 30513 Phone: 706-632-2085 |
Mark David Dlugokinski, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 101 Riverstone Vista, Ste 202, Blue Ridge, GA 30513 Phone: 706-258-4166 Fax: 706-258-4167 |
Dr. Russell A Seabolt, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 21 Kimberly Lane, Blue Ridge, GA 30513 Phone: 706-632-6800 Fax: 706-632-6802 |
Dr. Arman Ruhani Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 330 Progress Cir Ste C, Blue Ridge, GA 30513 Phone: 678-365-0322 |
 Dr. Candyce Jaye Thompson, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 330 Progress Cir Ste C, Blue Ridge, GA 30513 Phone: 678-365-0322 |
George Murray Talbot Jr., DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 990 E Main St, Suite 11, Blue Ridge, GA 30513 Phone: 706-258-3384 Fax: 706-374-7628 |
Dr. John David Walton, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 10075 Blue Ridge Drive, Blue Ridge, GA 30513 Phone: 706-632-2281 Fax: 706-258-4467 |
News Archive
Ludwig scientists develop and test individualized ovarian cancer vaccine
A Ludwig Cancer Research study has shown that an entirely new type of personalized cancer vaccine induces novel, potent and clinically effective immune responses in patients receiving a combination of standard therapies for recurrent, stage III and IV ovarian cancer.
Data shows rates of colorectal cancer screening vary by race, ethnicity and method
Rates of colorectal cancer screening vary by race and ethnicity as well as method, according to data being presented at Digestive Disease Week- 2010. Scientists examine data on minority and older populations as well as utilization rates of virtual and optical colonoscopies to better understand adherence to recommended screening guidelines.
New high precision machine-learning model could help accelerate drug discovery
Drug discovery could be significantly accelerated thanks to a new high precision machine-learning model, developed by an international collaboration of researchers, including the University of Warwick.
EC approves change in posology of Circadin from 3 weeks to 3 months of treatment
Neurim Pharmaceuticals confirmed today that the European Commission (EC) has approved a change in treatment duration with Circadin from 3 to 13 weeks (3 months). Circadin is indicated for the treatment of primary insomnia in patients who are aged 55 or over.
› Verified 7 days ago
Pharmacists
Counselors
Dentists
Psychologists
Occupational Therapists
Clinical Social Workers